Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-24-000785
Filing Date
2024-12-05
Accepted
2024-12-05 16:27:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3467
  Complete submission text file 0001971857-24-000785.txt   5035
Mailing Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921
Business Address 135 ROUTE 202/206 SUITE 6 BEDMINSTER NJ 07921 (646) 440-9333
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36274 | Film No.: 241529455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 135 ROUTE 202/206 BEDMINSTER NJ 07921
Business Address
Mates Sharon (Reporting) CIK: 0001585699 (see all company filings)

Type: 144